BIOMAT Database Logo BIOMAT Database Logo

Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. 2018

Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
a Chemistry of Natural Compounds Department , National Research Centre , Dokki , Egypt.

Herein, we report the synthesis of different novel sets of coumarin-6-sulfonamide derivatives bearing different functionalities (4a, b, 8a-d, 11a-d, 13a, b, and 15a-c), and in vitro evaluation of their growth inhibitory activity towards the proliferation of three cancer cell lines; HepG2 (hepatocellular carcinoma), MCF-7 (breast cancer), and Caco-2 (colon cancer). HepG2 cells were the most sensitive cells to the influence of the target coumarins. Compounds 13a and 15a emerged as the most active members against HepG2 cells (IC50 = 3.48 ± 0.28 and 5.03 ± 0.39 µM, respectively). Compounds 13a and 15a were able to induce apoptosis in HepG2 cells, as assured by the upregulation of the Bax and downregulation of the Bcl-2, besides boosting caspase-3 levels. Besides, compound 13a induced a significant increase in the percentage of cells at Pre-G1 by 6.4-folds, with concurrent significant arrest in the G2-M phase by 5.4-folds compared to control. Also, 13a displayed significant increase in the percentage of annexin V-FITC positive apoptotic cells from 1.75-13.76%. Moreover, QSAR models were established to explore the structural requirements controlling the anti-proliferative activities.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell

Related Publications

Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation.
December 2018, Journal of enzyme inhibition and medicinal chemistry,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
May 2017, Bioorganic & medicinal chemistry letters,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Design, synthesis, biological evaluation and QSAR studies of novel bisepipodophyllotoxins as cytotoxic agents.
August 2004, Bioorganic & medicinal chemistry,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation.
January 2024, RSC medicinal chemistry,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL COUMARIN DERIVATIVES AS ANTIOXIDANT AGENTS.
January 2015, Bioorganicheskaia khimiia,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Novel Thiazolidinone/Thiazolo[3,2-a]Benzimidazolone-Isatin Conjugates as Apoptotic Anti-proliferative Agents Towards Breast Cancer: One-Pot Synthesis and In Vitro Biological Evaluation.
June 2018, Molecules (Basel, Switzerland),
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers.
July 2023, RSC advances,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
January 2021, Anti-cancer agents in medicinal chemistry,
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Synthesis, 2D-QSAR Studies and Biological Evaluation of Quinazoline Derivatives as Potent Anti-Trypanosoma cruzi Agents.
January 2019, Medicinal chemistry (Shariqah (United Arab Emirates)),
Ahmed Sabt, and Omaima M Abdelhafez, and Radwan S El-Haggar, and Hassan M F Madkour, and Wagdy M Eldehna, and Ezz El-Din A M El-Khrisy, and Mohamed A Abdel-Rahman, and Laila A Rashed
Design, synthesis and biological evaluation of novel carbamodithioates as anti-proliferative agents against human cancer cells.
September 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!